Baxter International Inc.
General ticker "BAX" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $12.0B (TTM average)
Baxter International Inc. does not follow the US Stock Market performance with the rate: -22.0%.
Estimated limits based on current volatility of 2.0%: low 18.29$, high 19.05$
Factors to consider:
- Company included in S&P500 list
- Company pays dividends (quarterly): last record date 2026-05-29, amount 0.01$ (Y0.22%)
- Total employees count: 37500 (-1.3%) as of 2025
- US accounted for 0.3% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Strategic risks and growth management, Liquidity and credit risks, Market competition, New product monetization, Supply chain disruptions
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [12.86$, 25.79$]
- 2026-12-31 to 2027-12-31 estimated range: [14.67$, 27.80$]
Financial Metrics affecting the BAX estimates:
- Positive: with PPE of 8.4 at the end of fiscal year the price was neutral
- Positive: 6.59 < Operating cash flow per share per price, % of 8.61
- Negative: negative Net income
- Positive: -5.39 < Operating profit margin, % of -2.62
- Negative: Industry inventory ratio change (median), % of 1.78 > 0.28
- Positive: 19.24 < Shareholder equity ratio, % of 30.56 <= 42.59
- Positive: -0.03 < Industry operating cash flow per share per price (median), % of 1.51
- Positive: Interest expense per share per price, % of 2.42 <= 3.31
- Negative: 0 < Inventory ratio change, % of 0.20
Short-term BAX quotes
Relationship graph
Long-term BAX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $10,388.00MM | $10,648.00MM | $11,450.00MM |
| Operating Expenses | $9,681.00MM | $10,634.00MM | $11,758.00MM |
| Operating Income | $707.00MM | $14.00MM | $-308.00MM |
| Non-Operating Income | $-465.00MM | $-303.00MM | $-197.00MM |
| Interest Expense | $439.00MM | $341.00MM | $238.00MM |
| R&D Expense | $518.00MM | $590.00MM | $518.00MM |
| Income(Loss) | $242.00MM | $-289.00MM | $-505.00MM |
| Taxes | $61.00MM | $37.00MM | $395.00MM |
| Other Income(Loss) | $2,482.00MM | $-312.00MM | $-57.00MM |
| Net Income(Loss)* | $2,656.00MM | $-649.00MM | $-957.00MM |
| Stockholders Equity | $8,402.00MM | $6,964.00MM | $6,129.00MM |
| Inventory | $1,918.00MM | $2,046.00MM | $2,232.00MM |
| Assets | $28,276.00MM | $25,782.00MM | $20,055.00MM |
| Operating Cash Flow | $1,726.00MM | $1,019.00MM | $845.00MM |
| Capital expenditure | $436.00MM | $460.00MM | $522.00MM |
| Investing Cash Flow | $3,213.00MM | $-626.00MM | $2,841.00MM |
| Financing Cash Flow | $-3,489.00MM | $-1,081.00MM | $-4,216.00MM |
| Earnings Per Share** | $5.25 | $-1.27 | $-1.87 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.